Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients

Grant

Date/time Interval

  • August 30, 2017 - August 29, 2019
  • Total Award Amount

  • 13860.00
  • Direct Costs

  • 11000.00
  • Sponsor Award Id

  • Contributor

  • Matthew Kutny M.D.   Principal Investigator